Skip to main content
. Author manuscript; available in PMC: 2022 Sep 1.
Published in final edited form as: Pediatr Blood Cancer. 2021 Apr 21;68(9):e29065. doi: 10.1002/pbc.29065

TABLE 2.

Summary of DLTs

Dose Level Prexasertib Dose (mg/m2) Part No. of Patients Entered No. of Patients Evaluable No. of Patients with Cycle 1 DLTs No. of Patients with Later-Cycle DLTs
1 80 A 6 6 0 0
2 100 A 6 5 0 0
3 125 A 6 4 0 0
4 150 A 6 5 0 0
4 150 PK 6 5 0 0

Abbreviations: A= dose-escalation cohort; DLT= dose-limiting toxicity; No.= number; PK= Pharmacokinetic expansion cohort